To Study the Function of the Retina in Glaucoma Patients Using PERG

NCT03330574 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2022-05-05

No results posted yet for this study

Summary

The purpose of this trial is to evaluate the performance of a new diagnostic device in the diagnosis and management of glaucoma. We will use this new device (PERG) to evaluate the function of the retina in glaucoma patients. This device is safe for the patients.

Conditions

Sponsors & Collaborators

  • Swiss Vision Network

    lead OTHER

Principal Investigators

  • Kaweh Mansouri, MD · Glaucoma Center, Montchoisi Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2020-12-01
Completion
2023-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03330574 on ClinicalTrials.gov